Grand Pharmaceutical Group financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
HK$63.16M HK$46.38M HK$42.41M HK$49.05M HK$269.88M HK$545.44M HK$1.05B HK$1.65B HK$2.06B HK$2.66B HK$3.12B HK$3.25B HK$3.70B HK$4.77B HK$5.96B HK$6.59B HK$6.35B HK$8.60B HK$9.56B HK$0.00M HK$0.00M
GM % Gross Margin %
32.56% 43.31% 44.73% 46.19% 40.66% 45.85% 35.54% 31.26% 31.33% 33.35% 38.23% 41.61% 46.87% 51.97% 53.06% 61.32% 63.52% 61.03% 62.24% 0.00% 0.00%
OM Operating Margin
-101.68% -105.39% -56.96% -94.81% -2.86% 8.36% 4.41% 6.35% 7.15% 7.13% 9.61% 11.00% 12.38% 13.96% 14.98% 21.38% 28.35% 25.37% 31.02% 0.00% 0.00%
EPS Earnings Per Share
HK$0.07 HK$0.03 HK$0.12 HK$0.19 HK$0.27 HK$0.35 HK$0.52 HK$0.68 HK$0.59 HK$0.51 HK$0.00
Div. Dividends
HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.14 HK$0.11 HK$0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23.73% 21.57% 0
Sha. Shares
276.29m 1073.93m 1073.93m 1073.93m 1073.93m 1073.93m 1920.8m 1920.8m 1962.04m 1962.04m 1962.04m 1962.04m 2237.01m 2237.01m 3134.83m 3377.57m 3549.57m 3549.57m 3527.14m 0m 0m
OCF Operating Cash Flow
HK$-17.37M HK$-5.93M HK$-5.70M HK$-17.08M HK$28.08M HK$67.22M HK$184.10M HK$11.69M HK$292.62M HK$791.93M HK$477.30M HK$496.44M HK$774.97M HK$719.72M HK$1.41B HK$1.30B HK$1.46B HK$2.01B HK$1.84B HK$0.00M HK$0.00M
FCF Free Cash Flow
HK$-26.44M HK$-7.69M HK$-7.39M HK$-24.16M HK$11.24M HK$49.51M HK$133.49M HK$-260.13M HK$-441.68M HK$-85.72M HK$48.58M HK$29.88M HK$427.70M HK$425.35M HK$1.04B HK$737.91M HK$1.25B HK$1.53B HK$1.22B HK$2.32B HK$0.00M
FCFS Free Cash Flow Per Share
HK$-0.13 HK$-0.01 HK$-0.01 HK$-0.02 HK$0.01 HK$0.04 HK$0.08 HK$-0.14 HK$-0.23 HK$-0.04 HK$0.02 HK$0.01 HK$0.19 HK$0.17 HK$0.40 HK$0.22 HK$0.35 HK$0.41 HK$0.22 HK$0.00 HK$0.00